Feedback / Questions
Alzumab (itolizumab) - Biocon, Equillium, Ono Pharma
EQ101 - Equillium
EQ302 - Equillium
https://www.businesswire.com/news/home/20240808865281/en/Equillium-Reports-Second-Quarter-2024-Financial-Results-and-Provides-Recent-Corporate-and-Clinical-Highlights
Aug 8, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next